MAPS Public Benefit Corp. closed a $100 million Series A funding round and rebranded as Lykos Therapeutics, the company announced Thursday. The funding, which will support the company’s development of MDMA-assisted therapy for post-traumatic stress disorder, comes from a range of new investors, alongside the conversion of an undisclosed sum …

The Daily Hit is a recap of the top financial news stories for Jan. 4, 2024. On the Site California Cannabis Company Sues State, Alleges ‘Massive Overcollection’ of Taxes HNHPC Inc. – which is a wing of Long Beach-based Catalyst Cannabis Co. – has filed suit against several state agencies, …

President Joe Biden signed off on a new defense bill that includes provisions for funding clinical trials on the therapeutic potential of psychedelic drugs for active-duty military personnel. The president approved 2024’s National Defense Authorization Act on Dec. 22, a week after Congress green lit the package and sent it …